If you are able to add to the information on this page, please add a comment below.
Your comment will not be visible until approved by the website administrator.
Alternatively, you could complete our questionnaire (in English or en Français). The questionnaire will take less than 10 minutes to complete and is designed to quickly collect the information you have at your fingertips.
<<Back
Ghana
Population: 31.07m (2020)
Area: 238,535 sqkm
Diarrhoea deaths: 2,686 (2019)
ORS coverage: 48% (2018)
ORS + Zinc coverage: 27% (2018)
Download: Ghana’s Essential Medicines Lists (7th edition) 2017
National policy
✅ ORS+Zinc in National Clinical Guidelines
✅ ORS included in the National Essential Medicines List
✅ Zinc included in the National Essential Medicines List
❌ Co-packaged ORS & Zinc included in the National Essential Medicines List (as of Mar-2022)
Zinc availability
✅ Zinc available “over the counter”
❌ Any retailer can sell Zinc
Outlets for Zinc tablets:
✅ Pharmacies
✅ Drug stores/shops
❌ Supermarkets
❌ General retail outlets
❌ Community Health Workers
❌ Door-to-door sales people
✅ Government hospitals/clinics
✅ Private hospitals/clinics
❌ Campaigns and outreach
❌ Other
Co-pack availability
✅ Co-packaged ORS and Zinc available
Outlets for co-packaged ORS and Zinc tablets:
We need help to complete this section (please leave a comment if you can help)
❓ Pharmacies
❓ Drug stores/shops
❓ Supermarkets
❓ General retail outlets
❓ Community Health Workers
❓ Door-to-door sales people
❓ Government hospitals/clinics
❓ Private hospitals/clinics
❓ Campaigns and outreach
❓ Other
Co-packaged ORS and Zinc brands (may not be exhaustive)
PR Zinc and ORS
Co-packaged ORS and Zinc manufacturers (may not be exhaustive)
Phyto-Riker
Co-pack costs
Typical cost of a ORS/Zinc co-pack in the PUBLIC sector
???
Typical cost of a ORS/Zinc co-pack in the PRIVATE sector
???
❓ Diarrhoea programmes currently on-going
Name | Organisation | Funder | Diarrhoea specific | Target area |
Additional information
None
Information based on 1 questionnaire and 0 comments